Friday, 10 July 2009

Ortho Tri-Cyclen (Norgestimate+Ethinyl Estradiol): Teva stopped shipping the generic version till Preliminary Injunction decision

Teva Pharma (as per press release Here) has stopped shipping a generic version of innovator Johnson & Johnson's birth control pill Ortho Tri-Cyclen (Norgestimate / Ethinyl Estradiol).

Teva agreed to stop shipping the drug till a preliminary injunction hearing in a patent infringement lawsuit from innovator Johnson & Johnson.

The Preliminary Injunction hearing is scheduled to begin on July 15.

Earlier on July 1, 2009, Teva announced (announced in a press release Here) the generic approval and launch of Ortho Tri-Cyclen.

Posted by ADKS at 4:28 pm

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker